@article{ca209a8f34284760a82439028eabe974,
title = "Statin use in low-income and middle-income countries – Authors' reply",
author = "David Flood and Marcus, {Maja E.} and Bahendeka, {Silver K.} and Moghaddam, {Sahar Saeedi} and Corine Houehanou and Sebastian Vollmer and Huffman, {Mark D.}",
note = "Funding Information: MDH has patents pending for heart failure polypills. MDH has received meeting or travel support from the American Heart Association and World Heart Federation. MDH has an appointment at The George Institute for Global Health, which has a patent and licence, and has received investment funding with the intent to commercialise fixed-dose combination therapy through its social enterprise business called George Medicines. DF reports grant funding within the past 3 years from a Pilot and Feasibility Grant funded by the Michigan Center for Diabetes Translational Research (NIH Grant P30-DK092926) and a grant from the Swinmurn Foundation to implement a sustainable diabetes clinic in Guatemala. DF also reports volunteer affiliations with Wuqu{\textquoteright} Kawoq and GlucoSalud, outside of the submitted work. During the course of the study, DF received research fellowship funding from National Clinician Scholars Program at the University of Michigan Institute for Healthcare Policy and Innovation. All other authors declare no competing interests.",
year = "2022",
month = jul,
doi = "10.1016/S2214-109X(22)00217-0",
language = "English",
volume = "10",
pages = "e955--e956",
journal = "The Lancet Global Health",
issn = "2214-109X",
number = "7",
}